Among hematological cancers, somatic gain-of-function EZH2 mutations are found in lymphocytes of germinal-center origin in ~8% of patients with DLBCL and in ~20–25% of patients with FL, which are two types of NHL. The gene discussed is EZH2; the disease is diffuse large B-cell lymphoma.